AGP Executive Report
Last update: 5 hours agoPain & Menopause: Korean specialists advise resting and checking the cause of elbow or shoulder pain before it worsens. A menopause expert says hormone therapy can ease symptoms, with treatment choices based on each patient’s health risks. Obesity Care: With adult obesity at a record 35.4%, Hanmi’s Eppe has won approval as South Korea’s first homegrown GLP-1 obesity drug, with launch set for October. Reports say it may offer fewer side effects but less weight loss than imported options. Infection Watch: Legionella cases in Korea have risen 56%, with shopping malls among the reported hotspots. Biopharma: South Korean drug exports reached a record $6.6 billion in the first nine months of 2026, supported by demand from Europe.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.